EyeCon 2026 Banner
|Videos|July 22, 2021

Vyluma pipeline focuses on refractive error

Vyluma, which recently spun off from Nevakar, has a robust pipeline for potential therapies addressing refractive error. Navneet Puri, PhD, the company’s founder, chairman, and CEO, offers additional insights.


Latest CME